Biweekly Gemcitabine-Oxaliplatin and Dexamethasone for Relapsed/Refractory Malignant Lymphoma
Status:
Unknown status
Trial end date:
2009-10-01
Target enrollment:
Participant gender:
Summary
- To evaluate the feasibility of combination chemotherapies comprising of
gemcitabine-dexamethasone-oxaliplatin for patients with refractory or relapsed malignant
non-Hodgkin lymphoma (NHL)